Why the study?
Does partial inhibition of fatty acid oxidation with oxfenicine reduce lactate production and increase regional myocardial power during demand-induced ischemia in a swine model?
Population
Anesthetized open-chest swine with demand-induced ischemia (produced by reducing left anterior descending…
Comparison
Oxfenicine (2 mmol l(-1)) vs Vehicle
Design
Preclinical
Follow-up
20 minutes
Authors
Loading...
Hypothesis-generating for metabolic modulation in ischemia; leaves open clinical translation pending human trials.
Does partial inhibition of fatty acid oxidation with oxfenicine reduce lactate production and increase regional myocardial power during demand-induced ischemia in a swine model?
Partial inhibition of fatty acid oxidation with oxfenicine reduces non-oxidative glycolysis and improves regional contractile power and efficiency during demand-induced ischemia in a preclinical swine model.
Mary H.H. Chandler (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: